Biosafety Cabinets
Abcam Medetomidine hydrochloride, alpha2 adrenoceptor agonist, 50MG
MW 236.74 Da, Purity >99%. Selective α₂ adrenoceptor agonist (Ki values for receptor subtypes are 3.89 (α₂A), 7.40 (α₂B), 12.3 (α₂C) and 0.76 nM (α₂D)). Crosses the blood-brain barrier. Potent sedative, hypnotic and analgesic properties in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical PIn Thromboxn A2 10mg
PTA2 is a stable analog of TXA2. It is a TP receptor antagonist and an inhibitor of TX synthase.{516,794} PTA2 inhibits U-46619-induced cat coronary artery constriction (ID50 = 0.1 µM), U-46619-induced aggregation of human platelets (IC50 = 2 µM), and rabbit platelet TX synthase (ID50 = 50 µM). PTA2 does not affect PGI synthase up to a concentration of 100 µM.{516}
Cayman Chemical PIn Thromboxn A2 500ug
PTA2 is a stable analog of TXA2. It is a TP receptor antagonist and an inhibitor of TX synthase.{516,794} PTA2 inhibits U-46619-induced cat coronary artery constriction (ID50 = 0.1 µM), U-46619-induced aggregation of human platelets (IC50 = 2 µM), and rabbit platelet TX synthase (ID50 = 50 µM). PTA2 does not affect PGI synthase up to a concentration of 100 µM.{516}
Cayman Chemical PIn Thromboxn A2 1mg
PTA2 is a stable analog of TXA2. It is a TP receptor antagonist and an inhibitor of TX synthase.{516,794} PTA2 inhibits U-46619-induced cat coronary artery constriction (ID50 = 0.1 µM), U-46619-induced aggregation of human platelets (IC50 = 2 µM), and rabbit platelet TX synthase (ID50 = 50 µM). PTA2 does not affect PGI synthase up to a concentration of 100 µM.{516}